Showing results (121-130 of 142) with videos related to
Sort By:
Pageof 15
Annals of Hematology|April 6, 2011
Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulinsDeok-Hwan Yang, Mi-Hyun Kim, Youn-Kyung Lee, et al.Cancer Research|October 19, 2007
Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunityYutaro Nakamura, Payal Watchmaker, Julie Urban, et al.American Journal of Cancer Research|August 6, 2021
Immune cytolytic activity is associated with reduced intra-tumoral genetic heterogeneity and with better clinical outcomes in triple negative breast cancerMasanori Oshi, Tsutomu Kawaguchi, Li Yan, et al.Journal for Immunotherapy of Cancer|November 14, 2023
Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influxShipra Gandhi, Mateusz Opyrchal, Melissa J Grimm, et al.Journal of Personalized Medicine|May 25, 2024
Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast CancerRobert J Seager, Heidi Ko, Sarabjot Pabla, et al.Journal of Translational Medicine|December 21, 2007
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomasHideho Okada, Frank S Lieberman, Kevin A Walter, et al.Cancer Immunology Research|November 17, 2021
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer VaccineAmrita Basu, Gabriella K Albert, Sabrina Awshah, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2021
Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal CancerChristos Fountzilas, David L Bajor, Sarbajit Mukherjee, et al.Journal for Immunotherapy of Cancer|November 16, 2021
Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanomaWalter J Storkus, Deena Maurer, Yan Lin, et al.Journal for Immunotherapy of Cancer|November 14, 2024
Systemic chemokine-modulatory regimen combined with neoadjuvant chemotherapy in patients with triple-negative breast cancerShipra Gandhi, Ronald T Slomba, Cayla Janes, et al.Pageof 15